DK170989A - Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin - Google Patents

Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin

Info

Publication number
DK170989A
DK170989A DK170989A DK170989A DK170989A DK 170989 A DK170989 A DK 170989A DK 170989 A DK170989 A DK 170989A DK 170989 A DK170989 A DK 170989A DK 170989 A DK170989 A DK 170989A
Authority
DK
Denmark
Prior art keywords
receptor antagonist
protamin
thromboxan
prevent
side effects
Prior art date
Application number
DK170989A
Other languages
Danish (da)
English (en)
Other versions
DK170989D0 (da
Inventor
Martin Lawrence Ogletree
William Anthony Schumacher
Gary James Grover
Lawrence Tim Friedhoff
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK170989D0 publication Critical patent/DK170989D0/da
Publication of DK170989A publication Critical patent/DK170989A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK170989A 1988-04-11 1989-04-10 Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin DK170989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/179,694 US5066480A (en) 1988-04-11 1988-04-11 Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist

Publications (2)

Publication Number Publication Date
DK170989D0 DK170989D0 (da) 1989-04-10
DK170989A true DK170989A (da) 1989-10-12

Family

ID=22657593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK170989A DK170989A (da) 1988-04-11 1989-04-10 Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin

Country Status (12)

Country Link
US (1) US5066480A (de)
EP (1) EP0337697B1 (de)
JP (1) JPH0296537A (de)
AT (1) ATE92323T1 (de)
AU (1) AU624370B2 (de)
CA (1) CA1336953C (de)
DE (1) DE68907976T2 (de)
DK (1) DK170989A (de)
HU (1) HU206261B (de)
IE (1) IE63735B1 (de)
NZ (1) NZ228491A (de)
ZA (1) ZA892412B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132518A1 (en) * 1992-03-20 1993-09-30 Uma Sinha Glycosylation-mediated inhibition of factor x
US7356737B2 (en) * 2004-10-29 2008-04-08 International Business Machines Corporation System, method and storage medium for testing a memory module
US9693998B2 (en) 2014-05-16 2017-07-04 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
CN107708692A (zh) 2015-06-30 2018-02-16 坎伯兰医药品股份有限公司 Aerd/哮喘中的血栓烷受体拮抗剂
CN109152767B (zh) 2016-05-11 2022-10-21 坎伯兰医药品股份有限公司 用血栓烷-a2受体拮抗剂治疗肌营养不良的组合物和方法
CN117122687A (zh) 2017-11-29 2023-11-28 凡德贝尔大学 抑制肿瘤移转的方法
US11494695B2 (en) 2019-09-27 2022-11-08 Google Llc Training neural networks to generate structured embeddings

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
ZA827529B (en) * 1981-11-09 1983-09-28 Squibb & Sons Inc 7-oxabicycloheptane and 7-oxabicycloheptene compounds
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
CA1336953C (en) 1995-09-12
IE891061L (en) 1989-10-11
DK170989D0 (da) 1989-04-10
ZA892412B (en) 1990-01-31
EP0337697A2 (de) 1989-10-18
HU206261B (en) 1992-10-28
EP0337697A3 (en) 1990-08-16
AU624370B2 (en) 1992-06-11
HUT52372A (en) 1990-07-28
DE68907976D1 (de) 1993-09-09
IE63735B1 (en) 1995-06-14
AU3269189A (en) 1989-10-12
DE68907976T2 (de) 1994-03-31
US5066480A (en) 1991-11-19
ATE92323T1 (de) 1993-08-15
JPH0296537A (ja) 1990-04-09
NZ228491A (en) 1997-03-24
EP0337697B1 (de) 1993-08-04

Similar Documents

Publication Publication Date Title
DK170989A (da) Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin
ES2055114T3 (es) Isomerizacion de hidrocarburos fluorados saturados.
DK119387A (da) Stejltransportoer, isaer til losning af skibe
DE68900668D1 (de) Rotorkopf mit einer elastischen, innengedaempften, zwischenblattrueckholung.
DE68922235D1 (de) Durch Acetylen, Cyan oder Allen substituierte Aristeromycin- oder Adenosin-Derivate.
DE3786735D1 (de) Verminderung der verfaerbung von polyaminen durch milde katalytische hydrierung.
DE3689658D1 (de) Rufempfänger mit sprachsynthese durch lineare kodierungsvoraussage.
ATE154388T1 (de) Verwendung von modifiziertem heparin kofaktor ii
KR830006304A (ko) 디옥사이드 화합물의 제조방법
DK0624196T3 (da) Polypeptider med fibronectinbindingssteder som modulator for matrixopbygning.
DE58901632D1 (de) Bauelement zur verkleidung der fassaden von bauwerken.
GB1244167A (en) Improvements in or relating to the control of the motion of a reciprocating memnber
GB1483158A (en) Preparation of cyclododecatriene
DE3764986D1 (de) Monoazoverbindung mit einer faserreaktiven gruppe des vinylsulfon-typs, getragen von einem substituierten triazinbrueckenglied.
DK136887A (da) Prostacykliner, analoger heraf eller prostaglandiner og thromboxanantagonister til behandling af thrombotiske og thromboemboliske sygdomsbilleder
SU599086A1 (ru) Раздвижной верхн к крепи очистных забоев
JPS5373751A (en) Elevator system
FI895335A0 (fi) Foerfarande foer att stoppa en medelst en asynkronmotor driven horisontal trumma foersedd anordning i ett visst laege, och en tvaett- och/eller torkmaskin som tillaempar foerfarandet.
FR2566023B1 (fr) Plate-forme marine, notamment destinee a former une base de loisirs
GB1196460A (en) Improvements in Methods for the Production of Composite Girders
SU724758A1 (ru) Шарнирное соединение верхн ков
RU1581046C (ru) Органический сцинтилл тор
SE8202351L (sv) Farmaceutiskt preparat
SU672207A1 (ru) Полировальный состав дл оптических деталей
RO92553B1 (ro) Compozitie de acoperire pentru consolidarea suporturilor de zidarie

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment